Tokyo
Medical device manufacturer Irvine Scientific opened its Industrial Cell Culture media production facility in Tokyo in July of 2010. The 1,720-sm building will manufacture the company's cell culture media for production of biopharmaceuticals, vaccines, and monoclonal antibodies. Adhering to both ISO and FDA regulations, the facility will have the capacity to produce 600,000 kg of powdered media per year. Completion is expected in early 2011.
